Mail

Australia markets close in 1 hour 36 minutes

ALL ORDS
7,254.00
-82.10(-1.12%)
ASX 200
7,046.10
-78.60(-1.10%)
AUD/USD
0.6588
-0.0034(-0.52%)
OIL
73.15
+0.11(+0.15%)
GOLD
2,055.40
+13.20(+0.65%)
Bitcoin AUD
63,469.94
+1,484.63(+2.40%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

19.95

-0.02

(-0.10%)

At close: 04:00PM EST

19.95

0.00

(0.00%)

After hours:

04:20PM EST

Currency in USD

Valuation measures⁴

Market cap (intra-day)	537.40M
Enterprise value	322.18M
Trailing P/E	478.00
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.77
Price/book (mrq)	1.39
Enterprise value/revenue	1.68
Enterprise value/EBITDA	-5.08

Trading information

Stock price history

Beta (5Y monthly)	0.96
52-week change ³	-16.13%
S&P500 52-week change ³	16.58%
52-week high ³	29.59
52-week low ³	9.26
50-day moving average ³	16.32
200-day moving average ³	18.91

Share statistics

Avg vol (3-month) ³	253.12k
Avg vol (10-day) ³	192.77k
Shares outstanding ⁵	26.91M
Implied shares outstanding ⁶	26.91M
Float ⁸	25.97M
% held by insiders ¹	4.48%
% held by institutions ¹	85.72%
Shares short (14 Nov 2023) ⁴	1.3M
Short ratio (14 Nov 2023) ⁴	3.98
Short % of float (14 Nov 2023) ⁴	5.79%
Short % of shares outstanding (14 Nov 2023) ⁴	4.85%
Shares short (prior month 12 Oct 2023) ⁴	1.11M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2022
Most-recent quarter (mrq)	29 Sept 2023

Profitability

Profit margin	-39.32%
Operating margin (ttm)	-15.68%

Management effectiveness

Return on assets (ttm)	-11.95%
Return on equity (ttm)	-18.94%

Income statement

Revenue (ttm)	192.01M
Revenue per share (ttm)	7.21
Quarterly revenue growth (yoy)	66.10%
Gross profit (ttm)	105.03M
EBITDA	-73.5M
Net income avi to common (ttm)	-75.5M
Diluted EPS (ttm)	-2.84
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	229.75M
Total cash per share (mrq)	8.54
Total debt (mrq)	14.56M
Total debt/equity (mrq)	3.78%
Current ratio (mrq)	7.70
Book value per share (mrq)	14.35

Cash flow statement

Operating cash flow (ttm)	-30.21M
Levered free cash flow (ttm)	-15.35M